메뉴 건너뛰기
Molecular Imaging and Biology
Volumn 7, Issue 3, 2005, Pages 197-200
How available is positron emission tomography in the United States?
Author keywords

Center for Medicare and Medicaid Services; Mobile PET; PET availability; Reimbursement; United States
Indexed keywords

ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HUMAN; INFORMATION PROCESSING; INTERNET; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UNITED STATES; EDITORIAL; HOSPITAL; HOSPITAL EQUIPMENT; STATISTICS; UTILIZATION REVIEW;
EID: 24744447833     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11307-005-4116-8     Document Type: Article
Times cited : (12)
References (8)
  • 1
    • 25144471648 scopus 로고    scopus 로고
    • FDG PET detection of mild cognitive impairment with the cognitive decline index
    • Abstract
    • J Patterson D Lilien K Tainter et al. 2004 FDG PET detection of mild cognitive impairment with the cognitive decline index Biol Psychiatry 55 8-S1 54S Abstract
    • (2004) Biol. Psychiatry , vol.55 , Issue.8 SUPPL. 1
    • Patterson, J.1    Lilien, D.2    Tainter, K.3
  • 2
    • 0042815722 scopus 로고    scopus 로고
    • Expanded coverage of positron emission tomography (PET) scans and related claims processing changes
    • Department of Health and Human Services (DHHS). Health Care Financing Administration Publication 60AB. Transmittal AB-01-54. April 10
    • Department of Health and Human Services (DHHS) (2001). Expanded coverage of positron emission tomography (PET) scans and related claims processing changes. Health Care Financing Administration Publication 60AB. Transmittal AB-01-54. April 10
    • (2001)
  • 3
    • 25144518684 scopus 로고    scopus 로고
    • Decision memo for positron emission tomography (FDG) and other neuroimaging devices for suspected dementia
    • Center for Medicare and Medicaid Services (CMS). CAG-00088R. Sept 15
    • Center for Medicare and Medicaid Services (CMS) (2004). Decision memo for positron emission tomography (FDG) and other neuroimaging devices for suspected dementia. CAG-00088R. Sept 15
    • (2004)
  • 4
    • 0035845499 scopus 로고    scopus 로고
    • Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET)
    • 10.1073/pnas.19104419811526211
    • MJ Leon De A Convit OT Wolf et al. 2001 Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/ poitron-emission tomography (FDG/PET) Proc Natl Acad Sci U S A 98 10966-10971 10.1073/pnas.191044198 11526211
    • (2001) Proc. Natl. Acad. Sci. U. S. A. , vol.98 , pp. 10966-10971
    • De Leon, M.J.1    Convit, A.2    Wolf, O.T.3
  • 5
    • 0035853154 scopus 로고    scopus 로고
    • Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
    • 10.1073/pnas.061509598 1:CAS:528:DC%2BD3MXit1altrg%3D 11248079
    • EM Reiman RJ Caselli K Chen et al. 2001 Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proc Natl Acad Sci U S A 98 3334-3339 10.1073/pnas.061509598 1:CAS:528:DC%2BD3MXit1altrg%3D 11248079
    • (2001) Proc. Natl. Acad. Sci. U. S. A. , vol.98 , pp. 3334-3339
    • Reiman, E.M.1    Caselli, R.J.2    Chen, K.3
  • 6
    • 12944259210 scopus 로고    scopus 로고
    • Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
    • 10.1073/pnas.090106797 1:CAS:528:DC%2BD3cXjvFarsbs%3D 10811879
    • GW Small LM Ercoli DH Silverman et al. 2000 Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proc Natl Acad Sci U S A 97 6037-6042 10.1073/pnas.090106797 1:CAS:528:DC%2BD3cXjvFarsbs%3D 10811879
    • (2000) Proc. Natl. Acad. Sci. U. S. A. , vol.97 , pp. 6037-6042
    • Small, G.W.1    Ercoli, L.M.2    Silverman, D.H.3
  • 7
    • 0034974107 scopus 로고    scopus 로고
    • Hippocampal formation glucose metabolism and volume losses in MCI and AD
    • 1:CAS:528:DC%2BD3MXltVCqtro%3D 11445252
    • S Santi De MJ Leon de H Rusinek et al. 2001 Hippocampal formation glucose metabolism and volume losses in MCI and AD Neurobiol Aging 22 529-539 1:CAS:528:DC%2BD3MXltVCqtro%3D 11445252
    • (2001) Neurobiol. Aging , vol.22 , pp. 529-539
    • De Santi, S.1    de Leon, M.J.2    Rusinek, H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.